Copyright
©The Author(s) 2022.
World J Gastroenterol. Jun 21, 2022; 28(23): 2561-2568
Published online Jun 21, 2022. doi: 10.3748/wjg.v28.i23.2561
Published online Jun 21, 2022. doi: 10.3748/wjg.v28.i23.2561
No. | Considerations |
1 | Tumor exceeds “the up to seven" criteria |
2 | Tumor(s) larger than 5cm |
3 | Contiguous multinodular tumors |
4 | Poorly differentiated or undifferentiated HCC |
5 | No objective response to 2 consecvutive TACE treatments |
- Citation: Silk T, Silk M, Wu J. Up to seven criteria in selection of systemic therapy for hepatocellular carcinoma. World J Gastroenterol 2022; 28(23): 2561-2568
- URL: https://www.wjgnet.com/1007-9327/full/v28/i23/2561.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i23.2561